BioNexus Gene Lab Corp (BGLC)
0.604
-0.01
(-0.92%)
USD |
NASDAQ |
May 03, 16:00
0.60
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Cash from Operations (TTM): -1.302M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.302M |
| September 30, 2023 | -0.5629M |
| June 30, 2023 | 0.6453M |
| March 31, 2023 | 0.4714M |
| December 31, 2022 | 0.5518M |
| September 30, 2022 | 0.5581M |
| June 30, 2022 | 0.5651M |
| March 31, 2022 | -0.1441M |
| December 31, 2021 | 0.0092M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.4586M |
| June 30, 2021 | 0.8975M |
| March 31, 2021 | 1.646M |
| December 31, 2020 | 0.5527M |
| September 30, 2020 | -0.4382M |
| June 30, 2020 | -1.250M |
| March 31, 2020 | -1.146M |
| December 31, 2019 | -0.2173M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.302M
Minimum
Dec 2023
1.646M
Maximum
Mar 2021
0.0762M
Average
0.4586M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Balchem Corp | 183.76M |
| Friedman Industries Inc | 20.81M |
| Solitario Resources Corp | -3.263M |
| Golden Minerals Co | -9.912M |
| Paramount Gold Nevada Corp | -4.478M |